Real-world nationwide data from Germany reveals a shift in AMI presentation from STEMI to NSTEMI and highlights that in-hospital mortality remains high compared to selected trial populations.
No takes yet. Share an insight, caveat, or question.
Persistent high real-world AMI mortality amid NSTEMI shift; leaves open how to close the RCT gap in unselected patients.
Freisinger et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: